Apyx Medical Inc近日重申,公司继续预计截至2026年12月31日的财年运营支出将控制在4500万美元以内。这一预期体现了管理层对成本管控的持续承诺,同时也为未来业务发展保留了充足的财务灵活性。
Apyx Medical Inc近日重申,公司继续预计截至2026年12月31日的财年运营支出将控制在4500万美元以内。这一预期体现了管理层对成本管控的持续承诺,同时也为未来业务发展保留了充足的财务灵活性。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.